
- Total revenues in 3Q24 were $84.0 million compared to $93.6 million in the same quarter last year. Operational growth in the business was offset by a $15.7 million accrual of the compensatory payment from Syngenta, in comparison to a $32.9 million accrual in 3Q23.
- Operating profit was $13.2 million with GAAP net income at $9.8 million.
- Adjusted EBITDA1 for the quarter was $21.1 million, compared to $35.8 million in the year ago quarter. The decrease was driven by the lower compensatory payment accrual, partially softened by improved operational performance.
- Regulatory clearance in
Brazil unlocks bio-insecticidal/bio-nematicid al solutions, expanding Bioceres’ biologicals portfolio in this geography. - HB4 Soy varieties showed satisfactory performance at farmer level in Brazil, with an average yield improvement of 7% against non-HB4 varieties.
Read The Full Article – Biocerescrops

Leave a Reply